Arbutus Biopharma Corporation Earning Date (ABUS)

USA |NASDAQ |USD

ABUS Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Mar 2, 2022 Dec 2021 $-0.22 - $-0.23
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Mar 2, 2022 Dec 2021 $2.64M - $2.39M

Arbutus Biopharma Corporation's next earnings date is Wednesday, Mar 2, 2022 for the fiscal quarter ending Dec 2021.

ABUS Earnings Date & History Chart

ABUS Earnings & Revenue Forecast

ABUS Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $-0.22 $-0.24 $-0.19
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $-0.90 $-0.93 $-0.85
Dec 2022 5 $-0.82 $-1.02 $-0.61

ABUS Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.22 $-0.22 $-0.22
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.90 $-0.90 $-0.89
Dec 2022 0 / 0 $-0.79 $-0.75 $-0.76

ABUS Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 5 $2.64M $2.30M $3.80M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $9.57M $8.80M $11.00M
Dec 2022 4 $12.58M $9.30M $16.40M

ABUS Earnings Date & Revenue History

ABUS Earnings History

|
Show More
Show More

ABUS Revenue History

|
Show More
Show More

Arbutus Biopharma Corporation Next Earnings Date & Report

ABUS Next Earnings Date & Report Preview: Dec 2021 (FQ)

ABUS's next earnings date is Wednesday, Mar 2, 2022 for the fiscal quarter ending Dec 31, 2021.

According to analysts, the average EPS estimation for Arbutus Biopharma Corporation's next quarterly earnings is $-0.22, with a low EPS estimation of $-0.24, and a high estimation of $-0.19.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.22, the last 2 month trend is $-0.22, and the 3 month trend is $-0.22.

Based on analysts, the average revenue estimation is $2.64M, with a low revenue estimation of $2.30M, and a high estimation of $3.80M.

Arbutus Biopharma Corporation Previous Earnings Dates & Reports

ABUS Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Arbutus Biopharma Corporation's previous earnings date was Nov 1, 2021 for its fiscal quarter ended Sep 30, 2021.

ABUS Previous Earnings Date & Report Recap: Dec 2020 (FY)

Arbutus Biopharma Corporation's previous annual earnings date was Mar 4, 2021 for its fiscal year ended Dec 31, 2020.

ABUS's earnings per share (EPS) was $-1.00, missing the consensus analysts forecast of $-0.98 by 1.83% , and higher than the previous year's EPS (Dec 2019) by -65.46%.

Revenues were $6.91M, better than the forecast of $6.54M by 5.72%, and up by 15.02% from previous year's revenue.

The company reported a net income of $-63.74M.

Arbutus Biopharma Corporation reported a free cash flow of $-51.67M for its fiscal year, compared to $-71.59M a year ago.

The company ended the fiscal year with $2.98M in total debt, a decrease of -11.17% compared to the previous year.